Tsai, K., Hsieh, P., Chou, W., Cheng, H., Huang, Y., & Chan, S. (2021). Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK. Cell & Bioscience, 11(1), 1. https://doi.org/10.1186/s13578-021-00547-y
Chicago Style (17th ed.) CitationTsai, Kun-Ling, Pei-Ling Hsieh, Wan-Ching Chou, Hui-Ching Cheng, Yu-Ting Huang, and Shih-Hung Chan. "Dapagliflozin Attenuates Hypoxia/reoxygenation-caused Cardiac Dysfunction and Oxidative Damage Through Modulation of AMPK." Cell & Bioscience 11, no. 1 (2021): 1. https://doi.org/10.1186/s13578-021-00547-y.
MLA (9th ed.) CitationTsai, Kun-Ling, et al. "Dapagliflozin Attenuates Hypoxia/reoxygenation-caused Cardiac Dysfunction and Oxidative Damage Through Modulation of AMPK." Cell & Bioscience, vol. 11, no. 1, 2021, p. 1, https://doi.org/10.1186/s13578-021-00547-y.